Physician profile
Melvin M Maclin
NPI 1821198607
$4,861.25
in general payments reported to CMS, 2019-2025
16 companies · $21.12 in 2025
The $21.12 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,920 · 2020: $423 · 2021: $500 · 2022: $527 · 2023: $190 · 2024: $281 · 2025: $21.12.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $468 · Education: $24.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $467.90 |
| Education | $24.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $1,526.11 | 2019-2022 | |
| Kci USA, INC. | $1,161.72 | 2019-2021 | |
| Tepha INC | $867.56 | 2019-2020 | |
| Davol INC. | $196.24 | 2022 | |
| Abbvie INC. | $194.48 | 2023-2024 | |
| Ets Wound Care LLC | $190.99 | 2024 | Mirragen Advanced Wound Matrix |
| Allergan, INC. | $160.61 | 2019 | |
| Galderma Laboratories, L.P. | $121.69 | 2020-2022 | |
| Mentor Worldwide LLC | $107.09 | 2019-2022 | |
| Kls-Martin L.P. | $95.46 | 2021 | |
| Kerecis Limited | $70.62 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Bard Peripheral Vascular, INC. | $63.89 | 2021 | |
| Solventum Corporation | $60.91 | 2024 | Prevena, V.A.C.Ulta |
| Medtronic, INC. | $21.12 | 2025 | Inceptiv |
| Pacira Pharmaceuticals Incorporated | $11.60 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Advanced Oxygen Therapy INC. | $11.16 | 2024 | Topical Oxygen Chamber For Extremities |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melvin Maclin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.